Welcome to ENCITE

Quick Links

10th EMIM European Molecular Imaging Meeting

New! The 10th EMIM European Molecular Imaging Meeting will take place on 18-20 March 2015 in Tübingen, Germany.
Abstract Submission will open on 3rd November. Learn more on the
event website !


TOPIM Meeting on Imaging Inflammation

New! TOPIM stands for “hot TOPics in molecular IMaging”. This is a series of conferences much like the Gordon Conferences in the US or the original Keystone Symposia that runs for a week. The overall concept is that experienced, high-level scientists and younger scientists from different disciplines are spending one week together in an inspiring environment and to provide a platform for knowledge exchange and discussion.

The TOPIM Meeting on Imaging Inflammation takes place on 1-6 February 2015 in Pichl near Schladming, Austria.

Learn more!


ENCITE Session at ECR 2014!
There will be an ENCITE dedicated public session at the ECR 2014!
Date: Sunday, March 9, 2014: 16:00-17:30
Venue: ECR 2014, Austria Center Vienna, Room P
Please find the programme as well as further information here .


Educational course on small animal MR Imaging
One of the successful educational ENCITE events in 2012 was the ESMRMB Lecture on MR on Small Animal MRI. This year the course will be repeated under the auspices of ESMRMB and will take place in Münster/DE, October 10 - 12.

Learn more!


Successful conclusion of the ENCITE project
We are proud to announce that the ENCITE Project has been successfully concluded. We would like to thank everybody who contributed to this project. Please look out for the ENCITE special edition of Contrast Media & Molecular Imaging later this year.


Science to Practice
ENCITE cited in Science
Dual Contrast-enhanced MR Imaging to Monitor
for Rejection of Pancreatic Islet Transplantation?
Editorial in Radiogy by Olivier Clément/DESCARTES


Leiden debate focuses attention on future of imaging markers (AuntMinnie)
Hundreds of promising target molecules have been identified in preclinical studies for possible use as novel cell imaging agents. But how many are ever likely to be used in real patients? And who will pay the costs of the clinical trials needed to prove their value? Enjoy reading the press article!


Introduction



VISION

Develop and test new MR and optical imaging methods and biomarkers to get a more comprehensive picture of cell fate and the reaction of the immune system and to ultimately improve and further develop cell therapy for the benefit of the European patient.

ENCITE pays tribute to the hope of clinicians that one day tumour vaccines will prevent metastases in high risk tumour patients.

Please read ENCITE's Mission Statement on how the collaborating group applies the new Directive on the protection of animals used for experimental and other scientific purposes and the implementation of the three R's.

ENCITE - co-funded by the European Commission within the 7th Framework Programme for Research & co-ordinated by EIBIR.


Seventh Framework - EIBIR